ArticleJournal of gastrointestinal oncology2026
Efficacy and safety of sintilimab-based neoadjuvant regimens in patients with resectable gastric or gastroesophageal junction adenocarcinoma: a single-arm systematic review and meta-analysis.
Tingting Nan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.